Global Healthcare And Life Sciences — Operating Income
Ecolab Global Healthcare And Life Sciences — Operating Income increased by 16.0% to $32.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 71.4%, from $113.90M to $32.60M. Over 4 years (FY 2021 to FY 2025), Global Healthcare And Life Sciences — Operating Income shows a downward trend with a -6.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher operating income indicates superior segment profitability and effective cost control.
Detailed definition
Calculated as the segment's revenue minus its cost of goods sold and operating expenses, representing the core profitabi...
Peer comparison
Comparable to 'Segment Operating Profit' or 'EBIT' reported by competitors in the healthcare services and industrial chemicals sectors.
ecl_segment_global_healthcare_and_life_sciences_operating_income_lossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $48.30M | $37.30M | $29.70M | $44.10M | $58.50M | $34.70M | $67.70M | $35.00M | $32.70M | $44.00M | $48.30M | $37.00M | $33.70M | $35.80M | $113.90M | $25.20M | $34.80M | $28.10M | $32.60M |
| QoQ Change | — | -22.8% | -20.4% | +48.5% | +32.7% | -40.7% | +95.1% | -48.3% | -6.6% | +34.6% | +9.8% | -23.4% | -8.9% | +6.2% | +218.2% | -77.9% | +38.1% | -19.3% | +16.0% |
| YoY Change | — | — | — | — | +21.1% | -7.0% | +127.9% | -20.6% | -44.1% | +26.8% | -28.7% | +5.7% | +3.1% | -18.6% | +135.8% | -31.9% | +3.3% | -21.5% | -71.4% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Ecolab's global healthcare and life sciences — operating income?
- Ecolab (ECL) reported global healthcare and life sciences — operating income of $32.60M in Q4 2025.
- How has Ecolab's global healthcare and life sciences — operating income changed year-over-year?
- Ecolab's global healthcare and life sciences — operating income decreased by 71.4% year-over-year, from $113.90M to $32.60M.
- What is the long-term trend for Ecolab's global healthcare and life sciences — operating income?
- Over 4 years (2021 to 2025), Ecolab's global healthcare and life sciences — operating income has grown at a -6.9% compound annual growth rate (CAGR), from $160.90M to $120.70M.
- What does global healthcare and life sciences — operating income mean?
- The profit or loss generated by the segment from its core business operations.